These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 19358259)
21. Thin film rheology and lubricity of hyaluronic acid solutions at a normal physiological concentration. Tadmor R; Chen N; Israelachvili JN J Biomed Mater Res; 2002 Sep; 61(4):514-23. PubMed ID: 12115441 [TBL] [Abstract][Full Text] [Related]
22. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990 [TBL] [Abstract][Full Text] [Related]
23. A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome. McDonald CC; Kaye SB; Figueiredo FC; Macintosh G; Lockett C Eye (Lond); 2002 Sep; 16(5):601-7. PubMed ID: 12194076 [TBL] [Abstract][Full Text] [Related]
24. Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model. Niamprem P; Teapavarapruk P; Srinivas SP; Tiyaboonchai W Cornea; 2019 Apr; 38(4):485-491. PubMed ID: 30681516 [TBL] [Abstract][Full Text] [Related]
25. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study. Troiano P; Monaco G Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126 [TBL] [Abstract][Full Text] [Related]
26. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System. Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593 [TBL] [Abstract][Full Text] [Related]
27. Protective effect of uridine on cornea in a rabbit dry eye model. Oh JY; In YS; Kim MK; Ko JH; Lee HJ; Shin KC; Lee SM; Wee WR; Lee JH; Park M Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1102-9. PubMed ID: 17325152 [TBL] [Abstract][Full Text] [Related]
28. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops]. Ma ML; Liu L; Sun SY Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1246-8. PubMed ID: 16245899 [TBL] [Abstract][Full Text] [Related]
29. Viscoelastic and transient network properties of hyaluronic acid as a function of the concentration. De Smedt SC; Dekeyser P; Ribitsch V; Lauwers A; Demeester J Biorheology; 1993; 30(1):31-41. PubMed ID: 8374100 [TBL] [Abstract][Full Text] [Related]
30. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Felt O; Furrer P; Mayer JM; Plazonnet B; Buri P; Gurny R Int J Pharm; 1999 Apr; 180(2):185-93. PubMed ID: 10370189 [TBL] [Abstract][Full Text] [Related]
31. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
32. Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. Falcone SJ; Berg RA J Biomed Mater Res A; 2008 Oct; 87(1):264-71. PubMed ID: 18200557 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. Pavicic T; Gauglitz GG; Lersch P; Schwach-Abdellaoui K; Malle B; Korting HC; Farwick M J Drugs Dermatol; 2011 Sep; 10(9):990-1000. PubMed ID: 22052267 [TBL] [Abstract][Full Text] [Related]
34. Optimization of hyaluronan-based eye drop formulations. Salzillo R; Schiraldi C; Corsuto L; D'Agostino A; Filosa R; De Rosa M; La Gatta A Carbohydr Polym; 2016 Nov; 153():275-283. PubMed ID: 27561497 [TBL] [Abstract][Full Text] [Related]
35. Rheological properties of hyaluronic acid and its effects on salivary enzymes and candida. Park MS; Chang JY; Kang JH; Park KP; Kho HS Oral Dis; 2010 May; 16(4):382-7. PubMed ID: 20233322 [TBL] [Abstract][Full Text] [Related]
37. Assessment of in vitro bioactivity of hyaluronic acid and sulfated hyaluronic acid functionalized electroactive polymer. Cen L; Neoh KG; Li Y; Kang ET Biomacromolecules; 2004; 5(6):2238-46. PubMed ID: 15530038 [TBL] [Abstract][Full Text] [Related]
38. Viscosity changes in hyaluronic acid: irradiation and rheological studies. Daar E; King L; Nisbet A; Thorpe RB; Bradley DA Appl Radiat Isot; 2010; 68(4-5):746-50. PubMed ID: 19910202 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606 [TBL] [Abstract][Full Text] [Related]
40. In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment. La Gatta A; Corsuto L; Salzillo R; D'Agostino A; De Rosa M; Bracco A; Schiraldi C J Ocul Pharmacol Ther; 2018 Dec; 34(10):677-684. PubMed ID: 30325680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]